
A clinician may use the numerical value produced by this test to track the long-term duration of an individual’s immune response. Comparison of numerical results will help determine how the immune response develops in an individual and persists over time. The results of this semi-quantitative test should not be interpreted as an indication or degree of immunity or protection from re-infection.

Seroconversion can occur two to four weeks after exposure to COIVD-19 or vaccination. The test may be appropriate to establish seroconversion (the change from a non-detectable to a detectable level of antibodies in the blood). If you’ve been exposed to COVID-19 or received a COVID-19 vaccine, such as the Moderna or Pfizer vaccines, your body may have produced antibodies (anti-spike IgG) as part of the immune system response to the virus or vaccine.Ī clinician may be able to use this test to assess changes in the level of antibodies over time. Antibodies are believed to be one of the components of the immune systems that provide protection against viral infection - such as COVID-19. Therefore making it possible to follow the increase and/or decline of the antibodies either after an infection or vaccination.Īntibodies are proteins that the body produces in response (exposure) to an infection or vaccine.

Unlike most antibody tests, which provide a positive/negative response, the ADX Diagnostic Lab’s antibody test provides you with a numerical value that indicates the antibody level.

Our quantitative SARS-CoV-2 (COVID-19) IgG antibody test is designed to measure the level of the IgG antibodies against the Spike protein of SARS-COV-2 virus - the virus that causes COVID-19.
